Authors relationships and activities ES is a member of the Editorial Board of Diabetologia but was not involved in any of the decisions regarding review of this manuscript or its acceptance
Glucagon Like Peptide-1 (GLP-1) Likes Alzheimers Disease
The most common side effects include nausea (occurring in up to 44% of patients at weight-loss doses), vomiting (up to 25%), diarrhea (up to 30%), abdominal pain, and constipation
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights
Agents such as L-ornithine phenyl acetate, sodium benzoate, and zinc have been studied but lack sufficient evidence of efficacy to be recommended
Products like the PatchMD GLP-1 Support Patch provide a science-backed blend of nutrients that target key aspects of appetite regulation, blood sugar balance, and metabolic function